Vivo Capital as of March 31, 2020
Portfolio Holdings for Vivo Capital
Vivo Capital holds 53 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 20.4 | $226M | 2.0M | 112.61 | |
| New Frontier Health Corp ord | 10.7 | $118M | 14M | 8.25 | |
| Kadmon Hldgs | 4.8 | $53M | 13M | 4.19 | |
| Arcutis Biotherapeutics (ARQT) | 4.6 | $50M | 1.7M | 29.80 | |
| Crinetics Pharmaceuticals In (CRNX) | 4.4 | $49M | 3.3M | 14.70 | |
| Zymeworks | 3.5 | $39M | 1.1M | 35.47 | |
| Sinovac Biotech | 3.5 | $38M | 5.9M | 6.47 | |
| Forty Seven | 3.4 | $38M | 396k | 95.42 | |
| Passage Bio | 3.2 | $35M | 2.2M | 15.75 | |
| Flamel Technologies Sa | 2.6 | $28M | 3.6M | 7.94 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.0 | $22M | 769k | 28.77 | |
| Zogenix | 2.0 | $22M | 889k | 24.73 | |
| Verastem | 1.9 | $22M | 8.1M | 2.64 | |
| Selecta Biosciences | 1.7 | $19M | 7.8M | 2.41 | |
| Sierra Oncology | 1.7 | $19M | 1.9M | 9.82 | |
| Akero Therapeutics (AKRO) | 1.6 | $17M | 808k | 21.20 | |
| Codexis (CDXS) | 1.5 | $17M | 1.5M | 11.16 | |
| Amyris | 1.5 | $17M | 6.5M | 2.56 | |
| Karuna Therapeutics Ord | 1.5 | $16M | 224k | 72.00 | |
| Mei Pharma | 1.4 | $16M | 9.8M | 1.61 | |
| Homology Medicines | 1.4 | $16M | 1.0M | 15.54 | |
| Myokardia | 1.4 | $16M | 334k | 46.88 | |
| Aduro Biotech | 1.3 | $14M | 5.1M | 2.74 | |
| Orchard Therapeutics Plc ads | 1.1 | $12M | 1.6M | 7.53 | |
| Eiger Biopharmaceuticals | 1.1 | $12M | 1.8M | 6.80 | |
| Rocket Pharmaceuticals (RCKT) | 1.1 | $12M | 861k | 13.95 | |
| Kiniksa Pharmaceuticals | 1.1 | $12M | 759k | 15.48 | |
| Tricida | 1.0 | $12M | 524k | 22.00 | |
| Zai Lab (ZLAB) | 1.0 | $11M | 222k | 51.48 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $11M | 1.5M | 7.65 | |
| Igm Biosciences (IGMS) | 1.0 | $11M | 200k | 56.15 | |
| Avrobio Ord (AVRO) | 1.0 | $11M | 718k | 15.56 | |
| Menlo Therapeutics | 0.9 | $10M | 3.8M | 2.68 | |
| Trillium Therapeutics, Inc. Cmn | 0.8 | $8.3M | 2.1M | 4.04 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.7 | $7.3M | 447k | 16.33 | |
| Aurinia Pharmaceuticals (AUPH) | 0.7 | $7.3M | 501k | 14.51 | |
| Kala Pharmaceuticals | 0.6 | $6.9M | 787k | 8.79 | |
| Matinas Biopharma Holdings, In | 0.6 | $6.8M | 11M | 0.60 | |
| Black Diamond Therapeutics (BDTX) | 0.6 | $6.3M | 252k | 24.95 | |
| Verona Pharma Plc ads (VRNA) | 0.6 | $6.2M | 1.5M | 4.12 | |
| Soleno Therapeutics | 0.4 | $4.8M | 2.0M | 2.38 | |
| Chiasma | 0.4 | $4.6M | 1.3M | 3.65 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $4.5M | 397k | 11.34 | |
| Constellation Pharmceticls I | 0.4 | $4.4M | 140k | 31.43 | |
| Revolution Medicines (RVMD) | 0.4 | $4.4M | 200k | 21.91 | |
| Galmed Pharmaceuticals | 0.3 | $3.0M | 860k | 3.46 | |
| AtriCure (ATRC) | 0.2 | $2.2M | 65k | 33.59 | |
| Aclaris Therapeutics (ACRS) | 0.2 | $1.7M | 1.6M | 1.04 | |
| Cymabay Therapeutics | 0.1 | $1.6M | 1.1M | 1.48 | |
| Uniqure Nv (QURE) | 0.1 | $1.1M | 23k | 47.44 | |
| Dbv Technologies S A | 0.1 | $1.1M | 270k | 3.92 | |
| Nabriva Therapeutics | 0.1 | $980k | 1.7M | 0.58 | |
| Precision Biosciences Ord | 0.1 | $846k | 140k | 6.03 |
